Table 1 Baseline characteristics of the Sinikithemba paediatric cohort
Demography | [n (%)] |
|---|---|
Children | 151 |
Female | 77 (51.0%) |
Age | Â |
   < 3 years | 39 (25.8%) |
   3–5 years | 43 (28.5%) |
   6–8 years | 43 (28.5%) |
   ≥ 9 years | 26 (17.2%) |
   Median years [range] | 5.7 [.3–15.4] |
Parent status | [n (%)] |
   Two parents alive | 67 (44.4%) |
   Only father living | 19 (12.6%) |
   Only mother living | 27 (17.9%) |
   Neither parent living | 38 (25.1%) |
WHO clinical stage [n (%)] | [n (%)] |
   Stage 1 | 26 (17.2%) |
   Stage 2 | 19 (12.6%) |
   Stage 3 | 72 (47.7%) |
   Stage 4 | 34 (22.5%) |
Anthropometry | Median (IQR) |
   Weight-for-age Z-score | -1.9 (-3.6 to -0.9) |
   Height-for-age Z-score | -2.2 (-3.0 to -1.1) |
CD4 lymphocyte % | [n (%)] |
   < 5% | 52 (35.6%) |
   5%-9% | 36 (24.7%) |
   10%-14% | 28 (19.2%) |
   15%-24% | 26 (17.8%) |
   > 25% | 4 (2.7%) |
   Median CD4% (IQR) | 7.4 (2.1–13.7) |
Laboratory values | Median (IQR) |
   Albumin (g/L) | 30.0 (26.0–35.0) |
   ALT (IU/L) | 18.0 (14.0–28.3) |
   Hemoglobin (g/dl) | 10.1 (8.9–11.0) |
Tuberculosis | [n (%)] |
   Present | 50 (33.1%) |
Other opportunistic infections | [n (%)] |
   Chronic gastroenteritis | 52 (34.4%) |
   Pneumonia | 13 (8.6%) |
   Oesophageal candidiasis | 13 (8.6%) |
   PCP | 11 (7.3%) |
   Cryptococcal meningitis | 1 (0.7%) |
   CMV retinitis | 0 |
   Toxoplosmosis | 0 |